Molecular Analysis for Precision Oncology Congress 2023
- Start date
- 04 Oct 2023
- End date
- 06 Oct 2023
- Location
- Paris, France
The Molecular Analysis for Precision Oncology Congress (MAP) 2023 will take place on 4 and 5 October 2023 in Paris, France.
MAP is the leading congress in precision oncology, designed to provide the latest breaking data in the field of molecular profiling and personalised medicine.
The focus of the event is to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers.
Our globally recognised experts in clinical and precision oncology will welcome delegates for three days of discussions on the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.
The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.
The partner societies have the pleasure of introducing an additional special day at the conclusion of MAP 2023 on 6 October 2023: “RoadMAP to the Clinic 2023: From organ specific to biomarker driven drug development and approval”. Society experts and stakeholders from the scientific community, regulatory and HTA authorities, patient advocates, methodological experts and pharmaceutical industry representatives will participate in sessions comprising lectures and brainstorming discussion on this year’s theme ”How to transform development and registration of precision therapeutics in oncology from organ-specific to histology-agnostic and biomarker driven approvals”, in order to achieve molecularly informed, resource-rational and timely enrichment of the therapeutic armamentarium for our patients.
Organisation
MAP Congress Team
c/o ESMO Head Office
Via Ginevra 4
6900 Lugano
Switzerland
map@esmo.org